Skip to main content
Full access
Letters
Published Online: 1 July 2012

A Rare Case of Schizophrenia With Tongue Rupturation and Comorbid Analgesic Drug Abuse

Publication: The Journal of Neuropsychiatry and Clinical Neurosciences
To the Editor: Major self-mutilation is infrequent and usually occurs in relation with severe mental disorders which often results in permanent and/or totally loss of an organ or its function.1 In literature, several cases of severe disfigurement or marked self-mutilation in psychotic disorders such as bilateral self-enucleating, penectomy or castration, and penetrating cranio-cerebral injury were reported1,2 We report an unusual case with torn away of tongue by biting and comorbid oral analgesic use.

Case Report

A 39-year-old, unemployed man admitted to psychiatry outpatient service with his family because of his self mutilating behaviors. There were lacerations on wings of his nose and a piece of his tongue was deficient. The speech was in pressure but the content was poor. There were no hallucinations or delusions. He had blunted affect. He has bitten a piece of drug per two or three minutes during interview. He had no insight and the judgment was impaired. In history; his initial complaints had been persecution and reference delusions 15 years ago. Then he had begun to rub his eyes as nearly as enucleating them and had traumatized his face. He had struggled with his tooth and gingivas by his tongue thus the family has decided to have his front teeth have been pulled out. There were multiple hospitalizations and multiple treatments trials such as pimozide and clomipramine, flupenthixole decanoate, quetiapine, clonazepam since. He has been biting eight to ten tablets of analgesic drugs in a day for feeling ease for 2 years. He was reported to have ruptured his tongue one year before by rubbing his tongue to his rest of teeth, compulsively (see Figure 1). We initiated olanzapine and titrated up to 20mg/day while we have seen meaningful reductions in his self mutilating behaviors although he has continued to abuse analgesic drug.
Figure 1. The deficiency in right hemisphere of tongue and laceration in bilateral wings of nose can be seen

Discussion

Patients with schizophrenia are often suggested to be less sensitive to pain and usually this phenomenon was considered as “psychotic analgesia”.3 Although there was analgesic abuse in the present complaint of our case, at past he could not withstand compulsive behaviors such as: rubbing his hands to his own eyes as nearly enucleating them, or rubbing his hand to his wings of nose, leading to laceration without using any analgesic agent. It was mentioned that the more unusual the self-mutilation done, the higher possibility of the patient to be psychotic.2 Hallucinations, Schneider’s symptoms, delusions are well known risk factor for self mutilation in schizophrenia.4 Nevertheless, we could not find any relationship between florid positive psychotic symptoms and self-mutilating behaviors. Another interesting feature of this case was analgesic abuse and comorbid rupturing of tongue. However, the patient is still continuing to abuse analgesic agent after rupturation of his own tongue. Thus, analgesic drug abuse and schizophrenia comorbidity seems another explanation. Finally, successful treatment of self mutilation with olanzapine in psychotic disorders was reported in literature.5

References

1.
Large M, Babidge N, Andrews D, et al.: Major self-mutilation in the first episode of psychosis. Schizophr Bull 2009; 35:1012–1021
2.
Erdur B, Turkcuer I, Herken H: An unusual form of self-mutilation: tongue amputation with local anesthesia. Am J Emerg Med 2006; 24:625–628
3.
Dworkin RH: Pain insensitivity in schizophrenia: a neglected phenomenon and some implications. Schizophr Bull 1994; 20:235–248
4.
Ahuja N, Lloyd AJ: Self-cannibalism: an unusual case of self-mutilation. Aust N Z J Psychiatry 2007; 41:294–295
5.
Chengappa KNR, Rumble CT, Nasr F, et al.: Olanzapine use in subjects with pervasive developmental disorder displaying aggression and/or self-mutilation. J Psychiatr Pract 2001;7:156

Information & Authors

Information

Published In

Go to The Journal of Neuropsychiatry and Clinical Neurosciences
Go to The Journal of Neuropsychiatry and Clinical Neurosciences
The Journal of Neuropsychiatry and Clinical Neurosciences
Pages: E54 - E55
PubMed: 23037687

History

Published online: 1 July 2012
Published in print: Summer 2012

Authors

Details

Murat Emul, M.D.
Department of Psychiatry, Medical School of Cerrahpasa, Istanbul University, Turkey
Mihriban Dalkiran Varkal, M.D.
Department of Psychiatry, Medical School of Cerrahpasa, Istanbul University, Turkey
Musa Tosun, M.D.
Department of Psychiatry, Medical School of Cerrahpasa, Istanbul University, Turkey

Metrics & Citations

Metrics

Citations

Export Citations

If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Simply select your manager software from the list below and click Download.

For more information or tips please see 'Downloading to a citation manager' in the Help menu.

Format
Citation style
Style
Copy to clipboard

View Options

View options

PDF/EPUB

View PDF/EPUB

Login options

Already a subscriber? Access your subscription through your login credentials or your institution for full access to this article.

Personal login Institutional Login Open Athens login
Purchase Options

Purchase this article to access the full text.

PPV Articles - Journal of Neuropsychiatry and Clinical Neurosciences

PPV Articles - Journal of Neuropsychiatry and Clinical Neurosciences

Not a subscriber?

Subscribe Now / Learn More

PsychiatryOnline subscription options offer access to the DSM-5-TR® library, books, journals, CME, and patient resources. This all-in-one virtual library provides psychiatrists and mental health professionals with key resources for diagnosis, treatment, research, and professional development.

Need more help? PsychiatryOnline Customer Service may be reached by emailing [email protected] or by calling 800-368-5777 (in the U.S.) or 703-907-7322 (outside the U.S.).

Media

Figures

Other

Tables

Share

Share

Share article link

Share